Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Two-Compartment Open Model: IV Infusion01:15

Two-Compartment Open Model: IV Infusion

714
A two-compartment model is a vital tool in pharmacokinetics, providing an essential understanding of drug behavior, especially for those administered via zero-order intravenous infusion. This model outlines two compartments: the central compartment, where elimination occurs, and the peripheral compartment.
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
714
Compartment Models: Single-Compartment Model01:14

Compartment Models: Single-Compartment Model

3.6K
The single-compartment model serves as a simplified representation of the human body. This model assumes that the body functions as a single, well-mixed open compartment. When a drug is administered intravenously, it enters the body and quickly distributes uniformly. The drug then undergoes biotransformation and elimination, ultimately leaving the body. The volume of this compartment is referred to as the apparent volume of distribution into which the drug can uniformly distribute. In this...
3.6K
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

717
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
717
Compartment Models: Two-Compartment Model01:20

Compartment Models: Two-Compartment Model

7.6K
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
7.6K
Two-Compartment Open Model: Overview01:05

Two-Compartment Open Model: Overview

691
Multicompartmental models are crucial tools in pharmacokinetics, providing a framework to understand how drugs move within the body. The two-compartment model is a crucial subtype, segmenting the body into central and peripheral compartments. The central compartment represents areas with high blood flow, such as plasma and highly perfused organs like the kidneys and liver, while the peripheral compartment signifies tissues with lower blood flow, like adipose tissue and muscle tissue.
The...
691
Two-Compartment Open Model: Extravascular Administration01:12

Two-Compartment Open Model: Extravascular Administration

792
The two-compartment model for extravascular administration represents a drug's absorption and distribution process. It features a central compartment, where the drug is first absorbed, and a peripheral compartment, which illustrates the drug's distribution throughout the body. The rate of change in drug concentration in the central compartment is calculated by three exponents: absorption, distribution, and elimination.
The absorption exponent (ka) indicates the speed at which the drug...
792

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI-powered therapeutic aptamer drug discovery: Targeting the CT-domain of CTGF for duchenne muscular dystrophy.

Acta pharmaceutica Sinica. B·2026
Same author

SymBOL: A General-Purpose Symbolic Learner for Scientific Discovery Using Bayesian Optimization-Enhanced Large Language Models.

IEEE transactions on pattern analysis and machine intelligence·2026
Same author

From Five-Number Summary to Absolute Heterogeneity: Recent Methodological Advances in Meta-Analysis With Continuous Outcomes.

Journal of evidence-based medicine·2026
Same author

Non-Optimal Temperatures and Global Disease Burden: Retrospective Analysis of 2010-2021 and Projections to 2040.

Journal of occupational and environmental medicine·2026
Same author

An Inhibitory Aptamer Against PDGF-C Overcomes Anti-VEGF Refractoriness and Reduces Choroidal Neovascularization and Fibrosis.

Investigative ophthalmology & visual science·2026
Same author

PIEZO1 is Required for Acute Myeloid Leukemia Progression and Leukemia Stem Cell Maintenance via HIF1A-SLC7A11 Axis-Mediated Ferroptosis Defense.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Related Experiment Video

Updated: Mar 20, 2026

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

5.7K

Efficient Vaccine Distribution Based on a Hybrid Compartmental Model.

Zhiwen Yu1, Jiming Liu2, Xiaowei Wang1

  • 1School of Computer Science and Engineering, South China University of Technology, Guangzhou, Guangdong, China.

Plos One
|May 28, 2016
PubMed
Summary

This study introduces a hybrid SEIR-V model to optimize vaccine distribution for emerging infectious diseases. The model considers age and geographic factors to improve pandemic control strategies and reduce mortality.

More Related Videos

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.7K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.8K

Related Experiment Videos

Last Updated: Mar 20, 2026

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

5.7K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.7K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.8K

Area of Science:

  • Epidemiology
  • Mathematical Modeling
  • Public Health

Background:

  • Emerging infectious diseases pose significant public health threats, necessitating effective control strategies.
  • Current epidemic models often focus on age structure but lack geographical considerations.
  • Limited resources require efficient vaccine distribution planning during pandemics.

Purpose of the Study:

  • To develop a novel hybrid SEIR-V model integrating age and geographical dynamics for infectious disease spread.
  • To evaluate various vaccination strategies, including coverage, timing, and deployment methods.
  • To design and assess hybrid vaccination distribution strategies for enhanced epidemic control.

Main Methods:

  • Proposed a hybrid SEIR-V (susceptible-exposed-infectious-recovered-vaccine) compartmental model.
  • Incorporated age-specific population dynamics and geographical spread.
  • Developed four hybrid vaccination distribution strategies based on population size, contact patterns, infection rate, and risk.

Main Results:

  • The HSEIR-V model effectively simulates infectious disease dynamics considering both age and geographic factors.
  • Evaluated the impact of different vaccination coverages, release times, and deployment methods.
  • Demonstrated the utility of hybrid strategies in controlling viral spread using H1N1 data.

Conclusions:

  • The HSEIR-V model provides a comprehensive framework for understanding and managing infectious disease outbreaks.
  • Hybrid vaccination strategies offer a promising approach for optimizing resource allocation and mitigating epidemic impact.
  • The study highlights the importance of incorporating human behavior and geographical context in epidemic modeling.